RayThera
PulseAugur coverage of RayThera — every cluster mentioning RayThera across labs, papers, and developer communities, ranked by signal.
-
Autoimmune disease therapies boom amid VC investment; OpenAI targets healthcare
The field of autoimmune disease therapies is experiencing a significant boom, with projected revenues for drugs like AbbVie's Skyrizi expected to reach $33 billion by 2032. This growth is driven by scientific breakthrou…
-
Glass substrate tech gains market focus amid company R&D updates; Biogen eyes RayThera acquisition
The market is showing increased interest in glass substrate technology, spurred by TSMC's development plan. Several companies, including XingSen Technology, Medi-Tech, Vogue Optoelectronics, and Qibin Group, have announ…
-
Boston Scientific to acquire RayThera for up to $1B; SpaceX overtakes Amazon · 1 source tracked
Boston Scientific is set to acquire RayThera for up to $1 billion, a move aimed at expanding Boston Scientific's pipeline of investigational immunology products. The deal includes an upfront payment and additional payme…